ZETIA

This brand name is authorized in Brazil, Italy, Japan, United States

Active ingredients

The drug ZETIA contains one active pharmaceutical ingredient (API):

1 Ezetimibe UNII EOR26LQQ24 - EZETIMIBE

Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol. Read about Ezetimibe

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZETIA Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AX09	Ezetimibe	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AX Other lipid modifying agents
Discover more medicines within C10AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527314100015503, 527315120017317, 527315120017417
Country: IT	Agenzia del Farmaco	Identifier(s): 036017147
Country: JP	医薬品医療機器総合機構	Identifier(s): 2189018F1027
Country: US	FDA, National Drug Code	Identifier(s): 66582-414